Literature DB >> 9491278

Glomerular score as a prognosticator in IgA nephropathy: its usefulness and limitation.

R Katafuchi1, Y Kiyoshi, Y Oh, N Uesugi, K Ikeda, T Yanase, S Fujimi.   

Abstract

Glomerular sclerosis, mesangial hypercellularity, extracapillary lesions, interstitial fibrosis, and vascular sclerosis have been reported to be the significant pathologic prognosticators in IgA nephropathy (IgAN). We developed our own scoring for the following main glomerular changes in 248 patients with IgAN: 1) glomerular hypercellularity (mesangial and endocapillary), 2) segmental lesions such as tuft adhesion, crescent and segmental sclerosis, 3) global glomerular sclerosis. Indices of each lesion were semiquantitatively determined. The sum of these three indices was defined to be a glomerular score. We found that a glomerular score significantly related to the outcome of patients with IgAN in univariate life table analysis. We also semiquantitatively determined total score including tubulo-interstitial and vascular lesions as well as glomerular score and compared the predictive power as a prognosticator between glomerular score and total score. Using Cox's proportional Hazard model and log-likelihood ratio test, we confirmed that predictive power of glomerular score was better than that of total score. Furthermore, we assessed the reproducibility of glomerular score using Kappa statistics. Three pathologists read 100 biopsies which were randomly selected from the materials and all pathologists read them twice. A value of Kappa between the first and second observation of pathologist A, B and C was 0.68, 0.71 and 0.60, respectively. Values of Kappa between Pathologist A and B were ranging from 0.45 to 0.47, those between Pathologist A and C from 0.30 to 0.36, and finally those between Pathologist B and C were ranging from 0.12 to 0.23. Therefore, intra-observer reproducibility was nearly excellent. And inter-observer reproducibility between Pathologist A and B was satisfactory. However, inter-observer reproducibility between Pathologist A and C and between B and C was not satisfactory. We feel our scoring system is very convenient and easy to be understood as a prognosticator in patients with IgAN. It, however, should be used by one pathologist because of excellent intra-observer reproducibility and rather unsatisfactory inter-observer reproducibility.

Entities:  

Mesh:

Year:  1998        PMID: 9491278

Source DB:  PubMed          Journal:  Clin Nephrol        ISSN: 0301-0430            Impact factor:   0.975


  46 in total

1.  Pathology: Oxford IgA nephropathy classification: valid for children?

Authors:  Ryohei Yamamoto; Yasuyuki Nagasawa
Journal:  Nat Rev Nephrol       Date:  2010-11       Impact factor: 28.314

2.  The use of the Oxford classification of IgA nephropathy to predict renal survival.

Authors:  Eric Alamartine; Catherine Sauron; Blandine Laurent; Aurore Sury; Aline Seffert; Christophe Mariat
Journal:  Clin J Am Soc Nephrol       Date:  2011-09-01       Impact factor: 8.237

3.  Comparison of steroid-pulse therapy and combined with mizoribine in IgA nephropathy: a randomized controlled trial.

Authors:  Kosuke Masutani; Akihiro Tsuchimoto; Tomomi Yamada; Makoto Hirakawa; Koji Mitsuiki; Ritsuko Katafuchi; Hideki Hirakata; Takanari Kitazono; Kazuhiko Tsuruya
Journal:  Clin Exp Nephrol       Date:  2016-01-13       Impact factor: 2.801

4.  Serum suPAR levels help differentiate steroid resistance from steroid-sensitive nephrotic syndrome in children.

Authors:  Zhaoyang Peng; Jianhua Mao; Xuejun Chen; Fengqing Cai; Weizhong Gu; Haidong Fu; Huijun Shen; Jingjing Wang; Xia Jin; Xiujuan Zhu; Aimin Liu; Qiang Shu; Lizhong Du
Journal:  Pediatr Nephrol       Date:  2014-07-18       Impact factor: 3.714

5.  The Japanese Histologic Classification and T-score in the Oxford Classification system could predict renal outcome in Japanese IgA nephropathy patients.

Authors:  Ahmad Baseer Kaihan; Yoshinari Yasuda; Takayuki Katsuno; Sawako Kato; Takahiro Imaizumi; Takaya Ozeki; Manabu Hishida; Takanobu Nagata; Masahiko Ando; Naotake Tsuboi; Shoichi Maruyama
Journal:  Clin Exp Nephrol       Date:  2017-03-27       Impact factor: 2.801

6.  Reproducibility for pathological prognostic parameters of the Oxford classification of IgA nephropathy: a Japanese cohort study of the Ministry of Health, Labor and Welfare.

Authors:  Satoshi Hisano; Kensuke Joh; Ritsuko Katafuchi; Akira Shimizu; Noriaki Hashiguchi; Tetsuya Kawamura; Seiichi Matsuo
Journal:  Clin Exp Nephrol       Date:  2016-03-24       Impact factor: 2.801

7.  Expression and significance of TGF-beta1/Smad signaling pathway in children with IgA nephropathy.

Authors:  Wei Wu; Xiao-Yun Jiang; Qiao-Ling Zhang; Ying Mo; Liang-Zhong Sun; Shu-Mei Chen
Journal:  World J Pediatr       Date:  2009-08-20       Impact factor: 2.764

8.  Potential of renal pathology on refining syndrome typing of Chinese medicine in IgA nephropathy.

Authors:  Jian-Jun Li; Xiang-Mei Chen; Ri-Bao Wei
Journal:  Chin J Integr Med       Date:  2012-12-03       Impact factor: 1.978

9.  Renal parenchymal resistance in patients with biopsy proven glomerulonephritis: Correlation with histological findings.

Authors:  Antonietta Gigante; Biagio Barbano; Francesca Di Mario; Edoardo Rosato; Marzia Simonelli; Anna Rachele Rocca; Fabrizio Conti; Fulvia Ceccarelli; Konstantinos Giannakakis; Guido Valesini; Rosario Cianci
Journal:  Int J Immunopathol Pharmacol       Date:  2016-04-18       Impact factor: 3.219

10.  Expression of P311, a transforming growth factor beta latency-associated protein-binding protein, in human kidneys with IgA nephropathy.

Authors:  Fengping Wang; Xisheng Xie; Junming Fan; Li Wang; Dongyang Guo; Lichuan Yang; Xiaofen Ma; Lina Zhang; Zi Li
Journal:  Int Urol Nephrol       Date:  2009-11-28       Impact factor: 2.370

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.